Therefore, inhibition of IL-1β during CFA-induced arthritis can exacerbate inflammatory symptoms in the chronic phase by inhibiting the secretion of anti-inflammatory cytokines (Akhtari, Zaringhalam, Rohani, & Tekieh, 2013). The gene discussed is IL1B; the disease is arthritic joint disease.